|Articles|February 1, 2004

LCGC North America

  • LCGC North America-02-01-2004
  • Volume 22
  • Issue 2

Investigating Out-of-Specification Results

This column discusses potential sources and ways to avoid out-of-specification (OOS) results and highlights the draft FDA guidelines on OOS investigations.